Markers of androgen action, genetic variation and prostate cancer risk [ 2007 - 2009 ]

Research Grant

Researchers: Dr Gianluca Severi (Principal investigator) ,  A/Pr Justine Ellis ,  Prof Rodney Sinclair ,  Prof Vanessa Hayes

Brief description This proposal aim to follow up evidence from a number of studies that genetic and non-genetic markers of hormonal action in different periods of a man's life are associated with prostate cancer risk using a collection of three large, independent epidemiologic studies on prostate cancer named the Prostate Cancer Program. A principal objective is to collect exposure data on acne and digit ratio, and genotype cases and controls across the studies of the Prostate Cancer Program for common genetic variants in 4 candidate genes in the hormonal pathway. The established risk factors for prostate cancer are only age, race and family history. We anticipate that this project will cast light on the role of hormones in prostate cancer and that we will identify new markers of risk of prostate cancer and markers of disease aggressiveness. These outcomes will help us identifying men who are at risk for prostate cancer to target screening and surveillance, and plan prevention strategies. Furthermore, they will also form the basis for research on treatment targets.

Funding Amount $AUD 798,907.38

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant